TANG CAPITAL MANAGEMENT LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001232621

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth Tilt how tags are computed

Q3 2025 · 194 positions · Total reported value $2.60B · Top-10 concentration 36.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 15.2% · 5 new · 1 cut · 1 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.5% · vs SPY -10.6% · Prev Value $2.20B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.0% · vs SPY -5.2% · Latest Value $2.17B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, TANG CAPITAL MANAGEMENT LLC disclosed 194 equity positions with a combined reported value of $2.60B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 36.7% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt.

The largest disclosed positions as of Q3 2025 were TARS ($145.89M), LKFT ($143.80M), AUPH ($125.19M). By sector, the heaviest allocations are Health Care 80.8%, Consumer Discretionary 2.4%. Versus the prior quarter, allocation shifted toward Health Care (+5.9pp), Consumer Discretionary (+1.1pp) and away from Industrials (-2.3pp), Other (-4.1pp).

Versus the prior quarter, TANG CAPITAL MANAGEMENT LLC opened 5 new positions, trimmed 1 and fully exited 1, a turnover rate of 15.2% of positions. The portfolio's overlap with the prior quarter was 87% of names.

The largest new positions opened in Q3 2025 were CELC ($56.81M), PGEN ($40.80M), IDYA ($10.88M).

Of the 1 positions fully exited versus the prior quarter, the largest were ITOS ($38.15M), CRGX ($12.61M), ELAN ($11.43M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • CELC CELCUITY INC · $56.81M
  • PGEN PRECIGEN INC · $40.80M
  • IDYA IDEAYA BIOSCIENCES INC · $10.88M
  • PMVP PMV PHARMACEUTICALS INC · $6.70M
  • CRSP CRISPR THERAPEUTICS AG · $6.48M
  • VOR VOR BIOPHARMA INC · $2.44M
  • GOSS GOSSAMER BIO INC · $2.10M
  • CGTX COGNITION THERAPEUTICS INC · $1.62M

Fully Exited (vs previous quarter)

  • ITOS ITEOS THERAPEUTICS INC · prev qtr: $38.15M
  • CRGX CARGO THERAPEUTICS INC · prev qtr: $12.61M
  • ELAN ELANCO ANIMAL HEALTH INC · prev qtr: $11.43M
  • HLVX HILLEVAX INC · prev qtr: $9.79M
  • EPIX ESSA PHARMA INC · prev qtr: $7.31M
  • THRD THIRD HARMONIC BIO INC · prev qtr: $5.05M
  • NVAX NOVAVAX INC · prev qtr: $3.78M
  • SWTX SPRINGWORKS THERAPEUTICS INC · prev qtr: $3.49M

Insider Transactions (Form 4)

Latest TANG CAPITAL MANAGEMENT LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-10 Buy Boundless Bio, Inc. 249 $2.40 SEC filing
2026-11-06 Buy Boundless Bio, Inc. 1,700 $2.40 SEC filing
2026-11-05 Buy Boundless Bio, Inc. 8,390 $2.40 SEC filing
2026-11-04 Buy Boundless Bio, Inc. 517 $2.40 SEC filing
2026-11-03 Buy Boundless Bio, Inc. 2,255 $2.40 SEC filing
2026-10-27 Buy Boundless Bio, Inc. 10,707 $2.40 SEC filing
2026-10-26 Buy Boundless Bio, Inc. 9,606 $2.38 SEC filing
2026-10-23 Buy Boundless Bio, Inc. 6,234 $2.38 SEC filing

All insider transactions →

Fund Profile

Tang Capital Management is an SEC-registered 13F filer. As of Q3 2026 it reported 45 US equity positions with a combined value of $2.17B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 45 positions · $2.17B reported value (Q3 2026)
  • Top 10 holdings = 64.3% of reported value
  • Largest position: AUPH (AURINIA PHARMACEUTICALS INC) at 9.7%
  • Average position size: $48.31M

Sector Tilt

  • Health Care 89.7%
  • Information Technology 1.5%
  • (classified holdings cover 91% of value)

Quarterly Activity

  • Q3 2026: 5 new, 12 added, 1 reduced, 1 exited
  • 27 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 80.8%
Technology 2.0%
Financials 0.1%
Other 14.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.45M $145.89M 5.62%
5.62%
Hold
2 4.15M $143.80M 5.54%
5.54%
Add
3 11.33M $125.19M 4.82%
4.82%
Add
4 1.50M $92.06M 3.54%
3.54%
Add
5 1.24M $90.61M 3.49%
3.49%
Hold
6 2.33M $90.42M 3.48%
3.48%
Hold
7 2.31M $83.76M 3.22%
3.22%
Add
8 5.04M $61.41M 2.36%
2.36%
Add
9 2.84M $61.35M 2.36%
2.36%
Hold
10 16.81M $58.84M 2.27%
2.27%
Add
11 1.15M $56.81M 2.19%
2.19%
New
12 600.00K $56.49M 2.17%
2.17%
Hold
13 3.20M $53.63M 2.06%
2.06%
Hold
14 8.07M $42.12M 1.62%
1.62%
Hold
15 897.62K $41.81M 1.61%
1.61%
Hold
16 1.33M $40.84M 1.57%
1.57%
Hold
17 12.40M $40.80M 1.57%
1.57%
New
18 1.35M $39.23M 1.51%
1.51%
Hold
19 519.40K $36.22M 1.39%
1.39%
Add
20 550.00K $35.98M 1.39%
1.39%
Add
21 11.07M $35.30M 1.36%
1.36%
Hold
22 5.49M $33.70M 1.30%
1.30%
Add
23 2.10M $32.03M 1.23%
1.23%
Hold
24 1.50M $32.01M 1.23%
1.23%
Hold
25 80.00K $31.33M 1.21%
1.21%
Add
26 317.50K $29.08M 1.12%
1.12%
Hold
27 200.00K $28.80M 1.11%
1.11%
Hold
28 830.00K $27.07M 1.04%
1.04%
Hold
29 270.00K $26.63M 1.02%
1.02%
Hold
30 1.14M $26.01M 1.00%
1.00%
Hold
31 190.00K $25.04M 0.96%
0.96%
Hold
32 130.51K $24.35M 0.94%
0.94%
Hold
33 870.00K $22.86M 0.88%
0.88%
Add
34 1.42M $22.45M 0.86%
0.86%
Hold
35 150.00K $21.06M 0.81%
0.81%
Hold
36 1.00M $19.95M 0.77%
0.77%
Hold
37 1.95M $19.36M 0.74%
0.74%
Hold
38 26.01K $19.10M 0.73%
0.73%
Hold
39 1.10M $18.79M 0.72%
0.72%
Hold
40 400.00K $17.26M 0.67%
0.67%
Hold
41 700.00K $17.11M 0.66%
0.66%
Add
42 700.00K $16.73M 0.64%
0.64%
Hold
43 4.20M $15.54M 0.60%
0.60%
Add
44 1.05M $15.39M 0.59%
0.59%
Hold
45 7.06M $14.61M 0.56%
0.56%
Hold
46 3.40M $14.25M 0.55%
0.55%
Add
47 4.83M $14.00M 0.54%
0.54%
Reduce
48 1.78M $13.41M 0.52%
0.52%
Hold
49 1.85M $13.20M 0.51%
0.51%
Hold
50 2.60M $13.08M 0.50%
0.50%
Hold

FAQ

What did TANG CAPITAL MANAGEMENT LLC buy in 2025-Q3?

In its 2025-Q3 13F filing, TANG CAPITAL MANAGEMENT LLC reported 194 equity positions worth $2.60B in aggregate; its largest disclosed positions were TARS ($145.89M), LKFT ($143.80M), AUPH ($125.19M).

How large is TANG CAPITAL MANAGEMENT LLC's portfolio?

TANG CAPITAL MANAGEMENT LLC reported $2.60B of long equity holdings across 194 positions as of 2025-Q3. Top-10 holdings account for 36.7% of reported value.

What is TANG CAPITAL MANAGEMENT LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tang-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →